BioStock: Alligator Bioscience on the latest developments

Only a few weeks into the new year Alligator updated the market on the progression of the phase Ib/II study OPTIMIZE-1, a new research collaboration, and about a new major shareholder joining  Alligator’s nomination committee. BioStock reached out to CEO Søren Bregenholt to get his view on the latest developments.

Read the interview with Alligator Bioscience's CEO Søren Bregenholt at biostock.se:

https://www.biostock.se/2022/01/alligator-bioscience-on-the-latest-developments/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/